CN Stock MarketDetailed Quotes

603367 Cisen Pharmaceutical

Watchlist
  • 11.91
  • -0.17-1.41%
Market Closed Sep 13 15:00 CST
5.39BMarket Cap10.22P/E (TTM)

Cisen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-6.72%2.07B
1.28%1.15B
9.75%4.46B
10.23%3.21B
19.12%2.22B
30.43%1.13B
7.49%4.07B
5.61%2.91B
1.74%1.86B
-0.45%869.77M
Operating revenue
-6.72%2.07B
1.28%1.15B
9.75%4.46B
10.23%3.21B
19.12%2.22B
30.43%1.13B
7.49%4.07B
5.61%2.91B
1.74%1.86B
-0.45%869.77M
Other operating revenue
-9.24%3.33M
----
-33.81%11.14M
----
20.51%3.67M
----
74.86%16.83M
----
-35.44%3.05M
----
Total operating cost
-7.19%1.8B
-1.01%954.82M
4.01%3.87B
7.34%2.8B
15.58%1.94B
26.22%964.57M
5.11%3.72B
3.36%2.61B
1.55%1.68B
-1.50%764.17M
Operating cost
-11.65%874.86M
3.21%434.45M
2.78%1.84B
8.90%1.38B
17.87%990.27M
7.12%420.95M
6.21%1.79B
7.03%1.27B
8.98%840.16M
10.89%392.97M
Operating tax surcharges
-16.94%25.39M
-10.71%14M
7.25%59.38M
7.14%42.36M
21.97%30.57M
32.51%15.68M
10.05%55.37M
7.29%39.53M
0.28%25.07M
-4.12%11.84M
Operating expense
-8.20%599.25M
-9.17%340.42M
2.20%1.33B
5.03%946.67M
17.72%652.8M
56.88%374.77M
4.74%1.31B
-2.24%901.35M
-9.90%554.56M
-19.80%238.89M
Administration expense
8.78%139.11M
8.55%76.35M
12.60%292.41M
10.98%204.79M
3.94%127.88M
12.41%70.34M
13.05%259.7M
27.79%184.53M
41.22%123.03M
52.33%62.57M
Financial expense
-1.58%-17.18M
-17.30%-10.48M
-20.79%-33.67M
-12.77%-25.33M
-14.63%-16.92M
-27.44%-8.94M
-206.86%-27.88M
-247.50%-22.46M
-313.69%-14.76M
-1,448.66%-7.01M
-Interest expense (Financial expense)
-11.64%2.69M
20.13%1.35M
53.34%6.59M
56.13%4.93M
22.26%3.04M
-81.59%1.12M
-29.56%4.29M
-36.11%3.16M
-32.36%2.49M
144.92%6.1M
-Interest Income (Financial expense)
-1.06%-20.05M
-22.68%-12.05M
-21.18%-41.59M
-9.60%-29.06M
-11.92%-19.83M
44.41%-9.82M
-94.22%-34.32M
-111.42%-26.51M
-117.78%-17.72M
-701.57%-17.67M
Research and development
15.25%179.09M
9.05%100.07M
11.85%374.88M
5.60%255.42M
3.33%155.39M
41.37%91.77M
0.25%335.17M
-1.84%241.88M
-4.73%150.39M
-6.75%64.92M
Credit Impairment Loss
-169.23%-8.39M
-83.20%-12.54M
82.11%-2.34M
80.61%-3.2M
73.00%-3.12M
0.24%-6.85M
-320.85%-13.06M
-578.28%-16.48M
-82.68%-11.55M
-3,570.16%-6.86M
Asset Impairment Loss
-5.58%-37.78M
-56.01%-30.33M
-346.47%-73.5M
-71.20%-39.61M
-140.08%-35.78M
-311.66%-19.44M
22.70%-16.46M
4.12%-23.14M
44.94%-14.9M
14.65%-4.72M
Other net revenue
87.78%20.11M
-1,141.00%-11.65M
-119.16%-3.09M
489.98%14.14M
100.37%10.71M
155.98%1.12M
-81.82%16.11M
-105.18%-3.62M
-69.59%5.35M
-109.16%-2M
Fair value change income
-68.18%8.43M
-112.04%-2.08M
-232.56%-10.37M
338.54%8.83M
222.33%26.48M
664.50%17.25M
48.78%-3.12M
-126.97%-3.7M
-45.24%8.21M
104.18%2.26M
Invest income
17.36%18.31M
57.46%10.84M
136.18%44.12M
24.32%29.2M
29.08%15.6M
430.41%6.89M
-74.24%18.68M
-60.50%23.49M
-42.23%12.09M
-93.34%1.3M
-Including: Investment income associates
-99.95%120.55
----
117.58%132.27K
178.51%445.14K
134.43%254.99K
159.88%277.19K
-118.06%-752.52K
-102.88%-567.02K
-321.21%-740.64K
1.33%-462.9K
Asset deal income
-95.66%26.29K
5,811.69%2.52M
-39.03%594.29K
-16.05%571.31K
-11.07%605.21K
-93.74%42.62K
266.72%974.68K
568.49%680.53K
568.49%680.53K
1,146.25%680.53K
Other revenue
470.68%39.52M
517.56%19.93M
31.98%38.41M
18.14%18.34M
-35.96%6.92M
-39.69%3.23M
-22.05%29.1M
-34.03%15.52M
-28.79%10.81M
-19.41%5.35M
Operating profit
-0.11%290.12M
6.74%182.48M
62.54%592.58M
41.71%421.41M
52.57%290.43M
65.01%170.95M
9.02%364.58M
-1.24%297.38M
-3.00%190.36M
-13.47%103.6M
Add:Non operating Income
50.35%2.68M
3.26%1.32M
2.88%6.21M
-64.47%2.22M
-49.20%1.78M
-56.55%1.28M
26.60%6.03M
102.40%6.25M
49.27%3.51M
73.02%2.95M
Less:Non operating expense
-50.60%736.05K
-88.74%104K
-33.81%2.93M
-20.76%1.53M
323.69%1.49M
108.85%923.38K
44.82%4.43M
-17.21%1.93M
-84.19%351.69K
-80.12%442.13K
Total profit
0.46%292.06M
7.23%183.69M
62.72%595.86M
39.91%422.11M
50.23%290.72M
61.45%171.31M
8.94%366.19M
-0.06%301.7M
-1.46%193.52M
-10.99%106.1M
Less:Income tax cost
-23.02%18.35M
52.58%21.51M
405.97%70.43M
79.37%26.52M
144.27%23.83M
48.68%14.1M
524.20%13.92M
-10.47%14.79M
-29.16%9.76M
-10.25%9.48M
Net profit
2.56%273.72M
3.16%162.18M
49.15%525.43M
37.87%395.59M
45.24%266.89M
62.71%157.21M
5.50%352.27M
0.55%286.92M
0.63%183.76M
-11.06%96.62M
Net profit from continuing operation
2.56%273.72M
3.16%162.18M
49.15%525.43M
37.87%395.59M
45.24%266.89M
62.71%157.21M
5.50%352.27M
0.55%286.92M
0.63%183.76M
-11.06%96.62M
Less:Minority Profit
24.25%3.4M
-150.29%-681.86K
76.75%4.09M
194.96%5.14M
1,036.66%2.74M
1,144.54%1.36M
1,045.39%2.31M
-3,648.92%-5.41M
-201.33%-292.1K
-153.47%-129.79K
Net profit of parent company owners
2.33%270.32M
4.50%162.86M
48.97%521.34M
33.56%390.45M
43.52%264.15M
61.09%155.85M
4.73%349.96M
2.39%292.33M
0.74%184.05M
-10.99%96.75M
Earning per share
Basic earning per share
3.45%0.6
5.88%0.36
49.35%1.15
34.38%0.86
41.46%0.58
61.90%0.34
4.05%0.77
1.59%0.64
2.50%0.41
-12.50%0.21
Diluted earning per share
3.45%0.6
5.88%0.36
49.35%1.15
34.38%0.86
41.46%0.58
61.90%0.34
4.05%0.77
1.59%0.64
2.50%0.41
-12.50%0.21
Other composite income
155.90%451.37K
9,924.36%1.76M
360.50%244.78K
-3,803.33%-3.48M
-15.66%-807.5K
-97.48%17.6K
90.08%-93.97K
103.63%93.92K
74.76%-698.17K
130.14%699.38K
Other composite income of parent company owners
155.90%451.37K
9,924.36%1.76M
360.50%244.78K
-3,803.33%-3.48M
-15.66%-807.5K
-97.48%17.6K
90.08%-93.97K
103.63%93.92K
74.76%-698.17K
130.14%699.38K
Total composite income
3.04%274.17M
4.28%163.95M
49.26%525.67M
36.62%392.11M
45.35%266.08M
61.56%157.22M
5.77%352.18M
1.50%287.01M
1.79%183.06M
-8.47%97.32M
Total composite income of parent company owners
2.82%270.77M
5.62%164.63M
49.08%521.58M
32.33%386.97M
43.63%263.34M
59.95%155.87M
5.00%349.86M
3.36%292.42M
1.90%183.35M
-8.39%97.45M
Total composite income of minority owners
24.25%3.4M
-150.29%-681.86K
76.75%4.09M
194.96%5.14M
1,036.66%2.74M
1,144.54%1.36M
1,045.39%2.31M
-3,648.92%-5.41M
-201.33%-292.1K
-153.47%-129.79K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -6.72%2.07B1.28%1.15B9.75%4.46B10.23%3.21B19.12%2.22B30.43%1.13B7.49%4.07B5.61%2.91B1.74%1.86B-0.45%869.77M
Operating revenue -6.72%2.07B1.28%1.15B9.75%4.46B10.23%3.21B19.12%2.22B30.43%1.13B7.49%4.07B5.61%2.91B1.74%1.86B-0.45%869.77M
Other operating revenue -9.24%3.33M-----33.81%11.14M----20.51%3.67M----74.86%16.83M-----35.44%3.05M----
Total operating cost -7.19%1.8B-1.01%954.82M4.01%3.87B7.34%2.8B15.58%1.94B26.22%964.57M5.11%3.72B3.36%2.61B1.55%1.68B-1.50%764.17M
Operating cost -11.65%874.86M3.21%434.45M2.78%1.84B8.90%1.38B17.87%990.27M7.12%420.95M6.21%1.79B7.03%1.27B8.98%840.16M10.89%392.97M
Operating tax surcharges -16.94%25.39M-10.71%14M7.25%59.38M7.14%42.36M21.97%30.57M32.51%15.68M10.05%55.37M7.29%39.53M0.28%25.07M-4.12%11.84M
Operating expense -8.20%599.25M-9.17%340.42M2.20%1.33B5.03%946.67M17.72%652.8M56.88%374.77M4.74%1.31B-2.24%901.35M-9.90%554.56M-19.80%238.89M
Administration expense 8.78%139.11M8.55%76.35M12.60%292.41M10.98%204.79M3.94%127.88M12.41%70.34M13.05%259.7M27.79%184.53M41.22%123.03M52.33%62.57M
Financial expense -1.58%-17.18M-17.30%-10.48M-20.79%-33.67M-12.77%-25.33M-14.63%-16.92M-27.44%-8.94M-206.86%-27.88M-247.50%-22.46M-313.69%-14.76M-1,448.66%-7.01M
-Interest expense (Financial expense) -11.64%2.69M20.13%1.35M53.34%6.59M56.13%4.93M22.26%3.04M-81.59%1.12M-29.56%4.29M-36.11%3.16M-32.36%2.49M144.92%6.1M
-Interest Income (Financial expense) -1.06%-20.05M-22.68%-12.05M-21.18%-41.59M-9.60%-29.06M-11.92%-19.83M44.41%-9.82M-94.22%-34.32M-111.42%-26.51M-117.78%-17.72M-701.57%-17.67M
Research and development 15.25%179.09M9.05%100.07M11.85%374.88M5.60%255.42M3.33%155.39M41.37%91.77M0.25%335.17M-1.84%241.88M-4.73%150.39M-6.75%64.92M
Credit Impairment Loss -169.23%-8.39M-83.20%-12.54M82.11%-2.34M80.61%-3.2M73.00%-3.12M0.24%-6.85M-320.85%-13.06M-578.28%-16.48M-82.68%-11.55M-3,570.16%-6.86M
Asset Impairment Loss -5.58%-37.78M-56.01%-30.33M-346.47%-73.5M-71.20%-39.61M-140.08%-35.78M-311.66%-19.44M22.70%-16.46M4.12%-23.14M44.94%-14.9M14.65%-4.72M
Other net revenue 87.78%20.11M-1,141.00%-11.65M-119.16%-3.09M489.98%14.14M100.37%10.71M155.98%1.12M-81.82%16.11M-105.18%-3.62M-69.59%5.35M-109.16%-2M
Fair value change income -68.18%8.43M-112.04%-2.08M-232.56%-10.37M338.54%8.83M222.33%26.48M664.50%17.25M48.78%-3.12M-126.97%-3.7M-45.24%8.21M104.18%2.26M
Invest income 17.36%18.31M57.46%10.84M136.18%44.12M24.32%29.2M29.08%15.6M430.41%6.89M-74.24%18.68M-60.50%23.49M-42.23%12.09M-93.34%1.3M
-Including: Investment income associates -99.95%120.55----117.58%132.27K178.51%445.14K134.43%254.99K159.88%277.19K-118.06%-752.52K-102.88%-567.02K-321.21%-740.64K1.33%-462.9K
Asset deal income -95.66%26.29K5,811.69%2.52M-39.03%594.29K-16.05%571.31K-11.07%605.21K-93.74%42.62K266.72%974.68K568.49%680.53K568.49%680.53K1,146.25%680.53K
Other revenue 470.68%39.52M517.56%19.93M31.98%38.41M18.14%18.34M-35.96%6.92M-39.69%3.23M-22.05%29.1M-34.03%15.52M-28.79%10.81M-19.41%5.35M
Operating profit -0.11%290.12M6.74%182.48M62.54%592.58M41.71%421.41M52.57%290.43M65.01%170.95M9.02%364.58M-1.24%297.38M-3.00%190.36M-13.47%103.6M
Add:Non operating Income 50.35%2.68M3.26%1.32M2.88%6.21M-64.47%2.22M-49.20%1.78M-56.55%1.28M26.60%6.03M102.40%6.25M49.27%3.51M73.02%2.95M
Less:Non operating expense -50.60%736.05K-88.74%104K-33.81%2.93M-20.76%1.53M323.69%1.49M108.85%923.38K44.82%4.43M-17.21%1.93M-84.19%351.69K-80.12%442.13K
Total profit 0.46%292.06M7.23%183.69M62.72%595.86M39.91%422.11M50.23%290.72M61.45%171.31M8.94%366.19M-0.06%301.7M-1.46%193.52M-10.99%106.1M
Less:Income tax cost -23.02%18.35M52.58%21.51M405.97%70.43M79.37%26.52M144.27%23.83M48.68%14.1M524.20%13.92M-10.47%14.79M-29.16%9.76M-10.25%9.48M
Net profit 2.56%273.72M3.16%162.18M49.15%525.43M37.87%395.59M45.24%266.89M62.71%157.21M5.50%352.27M0.55%286.92M0.63%183.76M-11.06%96.62M
Net profit from continuing operation 2.56%273.72M3.16%162.18M49.15%525.43M37.87%395.59M45.24%266.89M62.71%157.21M5.50%352.27M0.55%286.92M0.63%183.76M-11.06%96.62M
Less:Minority Profit 24.25%3.4M-150.29%-681.86K76.75%4.09M194.96%5.14M1,036.66%2.74M1,144.54%1.36M1,045.39%2.31M-3,648.92%-5.41M-201.33%-292.1K-153.47%-129.79K
Net profit of parent company owners 2.33%270.32M4.50%162.86M48.97%521.34M33.56%390.45M43.52%264.15M61.09%155.85M4.73%349.96M2.39%292.33M0.74%184.05M-10.99%96.75M
Earning per share
Basic earning per share 3.45%0.65.88%0.3649.35%1.1534.38%0.8641.46%0.5861.90%0.344.05%0.771.59%0.642.50%0.41-12.50%0.21
Diluted earning per share 3.45%0.65.88%0.3649.35%1.1534.38%0.8641.46%0.5861.90%0.344.05%0.771.59%0.642.50%0.41-12.50%0.21
Other composite income 155.90%451.37K9,924.36%1.76M360.50%244.78K-3,803.33%-3.48M-15.66%-807.5K-97.48%17.6K90.08%-93.97K103.63%93.92K74.76%-698.17K130.14%699.38K
Other composite income of parent company owners 155.90%451.37K9,924.36%1.76M360.50%244.78K-3,803.33%-3.48M-15.66%-807.5K-97.48%17.6K90.08%-93.97K103.63%93.92K74.76%-698.17K130.14%699.38K
Total composite income 3.04%274.17M4.28%163.95M49.26%525.67M36.62%392.11M45.35%266.08M61.56%157.22M5.77%352.18M1.50%287.01M1.79%183.06M-8.47%97.32M
Total composite income of parent company owners 2.82%270.77M5.62%164.63M49.08%521.58M32.33%386.97M43.63%263.34M59.95%155.87M5.00%349.86M3.36%292.42M1.90%183.35M-8.39%97.45M
Total composite income of minority owners 24.25%3.4M-150.29%-681.86K76.75%4.09M194.96%5.14M1,036.66%2.74M1,144.54%1.36M1,045.39%2.31M-3,648.92%-5.41M-201.33%-292.1K-153.47%-129.79K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data